Although previous studies have established the relationship between NF-κB signaling and immune responses in sepsis, our findings suggest that SUMOylation may modulate these pathways in a more subtle manner, potentially influencing the survival and activation of immune cells. The gene discussed is NFKB1; the disease is Sepsis.